Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
141
NMPA:141
Drug Approvals
Lenvatinib Mesilate Capsules
- Product Name
- 甲磺酸仑伐替尼胶囊
- Approval Number
- 国药准字H20253102
- Approval Date
- Jan 8, 2025
NMPA
Lenvatinib Mesilate Capsules
- Product Name
- 甲磺酸仑伐替尼胶囊
- Approval Number
- 国药准字H20253101
- Approval Date
- Jan 8, 2025
NMPA
Lysine Acetylsalicylate for Injection
- Product Name
- 注射用赖氨匹林
- Approval Number
- 国药准字H20247087
- Approval Date
- Apr 26, 2024
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20243160
- Approval Date
- Feb 6, 2024
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20243161
- Approval Date
- Feb 6, 2024
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20243162
- Approval Date
- Feb 6, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
Clinical Trials
No trials found
News
No news found